CVS Point-Of-Sale Rebate Program Adopted By 'Several' Payers
Manufacturer rebates can be used to reduce patient cost sharing at point of sale under the PBM's program. There is growing interest in the idea as a solution to lowering drug costs, but the practice could drive up insurance premiums.
You may also be interested in...
Lilly CEO David Ricks reflects on the state of play on drug pricing issues on Capitol Hill and in the Administration and the challenges he sees ahead.
Analysis funded by Pharmaceutical Care Management Association concludes that using drug rebates to lower beneficiary cost sharing at the point-of-sale would raise premiums and increase government spending.
PhRMA ad campaign targets US payer practice of using drug rebate dollars for general premium and cost sharing reductions and not to lower the cost of specific prescription fills.